medicines


Articles

Acuerdo Transpacífico afectará soberanía en las políticas de salud

10-Apr-2015 La República Texto que negocian en secreto el Perú y otros 11 países, entre ellos EE.UU., plantea ampliar patentes de fármacos por encima de los 20 años, generando millonarios sobrecostos a nuestro sistema de salud y dificultando todavía más el acceso a las medicinas biológicas contra el cáncer.

  • 8-Jun-2011 PharmaBiz
    Health groups call for moratorium on FTAs, TRIPS-plus measures by developed nations

    As the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011, networks of People living with HIV, health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements (FTAs) and TRIPS-plus measures.

  • 2-Jun-2011
    Wrestling with Big Pharma

    Canadians spend a lot of money (public and private) on health care and much of that is spent on drugs — some $23.4 billion in 2008. Provincial insurance plans are desperately trying to cope, looking to initiatives like the recently passed Ontario law that caps prices of generic drugs at 25 per cent of the brand name equivalent.

  • 30-May-2011
    Goff: Pharmac ’absolute bottom line’

    Labour leader Phil Goff says his party would not put government drug buying agency Pharmac on the block to gain a free trade deal with the United States.

  • 29-May-2011 KEI
    Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries

    KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies.

  • 23-May-2011
    Protect Pharmac from US FTA - Greens

    The Green Party is calling on the Government to take Pharmac off the table in Trans Tasman Partnership (TTP) negotiations.

  • 15-May-2011
    Pharmac under fire ahead of US free-trade talks

    Some of New Zealand’s most prominent businesspeople are rallying to the support of drug buying body Pharmac as lobbying firm Saunders Unsworth mounts a campaign against the agency ahead of free trade negotiations with the US.

  • 12-May-2011 FDA News
    PhRMA calls for strong IP protection for biologics in TPP FTA

    US pharmaceutical industry association the Pharmaceutical Research and Manufacturers of America is calling on the US Trade Representative to include strong intellectual property provisions, such as 12-year data protection for follow-on biologics, in the Trans-Pacific Partnership agreement.

  • 6-May-2011
    India, Mercosur "must withstand EU pharma demands"

    Nations currently negotiating trade deals with the European Union (EU) have been warned that they must resist European demands which could threaten access to medicines in emerging and developing countries.

  • 5-May-2011
    No compromise in our stance on IPR, says India

    India will not compromise its stand or take a position on intellectual property rights (IPR), especially on pharmaceuticals, beyond its domestic law and agreements as mandated under the aegis of the global trade body—World Trade Organization (WTO).

  • 1-May-2011 ANSA Latina
    Preocupación de laboratorios por TLC y trabas aduaneras

    BUENOS AIRES, 1 (ANSA) - Los laboratorios de capital nacional de América Latina debatirán a partir de mañana en El Salvador sobre las consecuencias de los tratados de libre comercio en la región y sobre la imposición de trabas aduaneras, que alientan la concentración monopólica de los mercados farmacéuticos.

  • 13-Apr-2011 ActUp Paris
    Guerre aux labos : La politique européenne tue

    Par le passé, les États-Unis ont signé avec des pays en développement des accords de libre-échange (ALE), aux effets désastreux sur les coûts des médicaments. Depuis quelques années, c’est au tour de l’Europe, sous l’impulsion de la France, du Royaume-Uni et de l’Allemagne, de prendre le relais de cette politique bilatérale, lourde de conséquences pour les malades.

  • 12-Apr-2011 FSRN
    India-EU FTA carries severe public health consequences

    After four years of talks, India and the European Union are narrowing down their differences on a bilateral Free Trade Agreement that critics in India and elsewhere say could have a devastating impact on public health by hampering access to life-saving drugs for millions of people.

  • 7-Apr-2011 MSF
    Europe opens new front against affordable medicines in trade deal with India

    As free trade agreement talks between Europe and India resume in Brussels today, the international medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about new measures Europe is pushing to restrict the production of affordable generic medicines that MSF and others rely on to treat patients across the developing world.

  • 29-Mar-2011
    No data sharing on drugs of pharma cos in FTAs: Sharma

    India today ruled out sharing test data of drugs, or data exclusivity, of Indian pharma firms with developed countries and multi-national companies, and stressed that the provision will not form part of any free trade agreements pursued by the country.

  • 22-Mar-2011 Rue89
    Médicaments : l’Europe menace les génériques des pays pauvres

    L’accord, en négociation depuis trois ans, pourrait mettre un coup d’arrêt à la production de médicaments génériques en Inde.

  • 22-Mar-2011 KEI
    UN Special Raporteur on right to health asked to intervene in TPP Trade negotiation

    Eleven public interest advocacy groups and three law professors have submitted a petition to Anand Grover, the Special Rapporteur for the United Nations on the right to health, to intervene in a new regional trade agreement that will shrink the market for legal generic medecines.

  • 19-Mar-2011
    HAI Europe on EU-India & EU-Mercosur trade agreements

    All eyes are on the EU-India trade agreement, and the repercussions it will have on access to medicines in India and other developing countries. At the same time, the EU is in the process of negotiating other trade agreements that could harm or hinder access to medicines, such as this week’s negotiations between the EU and the Mercosur countries.

  • 15-Mar-2011
    Govt will protect interests of drug industry: Scindia

    Amid concerns expressed by the Indian industry, the government today said in Parliament that it will protect the interest of the domestic drug industry while finalising the free trade pact with European Union.

  • 15-Mar-2011
    India, EU settle generics dispute, pave way for FTA talks in April

    India has sorted out most of its differences with the European Union on production of low-cost generic medicines, ahead of a crucial meeting on a proposed free-trade pact next month, a government official told ET. Civil society groups, however, warn that India should be on its guard to ensure that the intellectual property rights (IPR) regime is not changed to allow extension of patents.

  • 8-Mar-2011 Act Up Paris
    Global e-protest against FTAs

    Write to members of Indian governement and European Commission to save affordable medicines and access to life-saving treatments in Africa, Asia and Latin America !

  • 0 | ... | 60 | 80 | 100 | 120 | 140 | 160 | 180 | 200 | 220 | ... | 480